Intuitive Surgical, Inc. (NASDAQ:ISRG) is Carderock Capital Management Inc.’s 6th Largest Position

Carderock Capital Management Inc. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,708 shares of the medical equipment provider’s stock after selling 355 shares during the period. Intuitive Surgical accounts for 2.8% of Carderock Capital Management Inc.’s portfolio, making the stock its 6th biggest position. Carderock Capital Management Inc.’s holdings in Intuitive Surgical were worth $11,331,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Moors & Cabot Inc. lifted its holdings in shares of Intuitive Surgical by 2.3% during the second quarter. Moors & Cabot Inc. now owns 1,159 shares of the medical equipment provider’s stock valued at $516,000 after purchasing an additional 26 shares during the last quarter. Intech Investment Management LLC increased its position in Intuitive Surgical by 6.2% during the 2nd quarter. Intech Investment Management LLC now owns 21,279 shares of the medical equipment provider’s stock valued at $9,466,000 after buying an additional 1,244 shares in the last quarter. Ieq Capital LLC raised its stake in Intuitive Surgical by 10.7% during the second quarter. Ieq Capital LLC now owns 27,040 shares of the medical equipment provider’s stock valued at $12,029,000 after buying an additional 2,616 shares during the last quarter. Trust Investment Advisors bought a new stake in Intuitive Surgical in the second quarter worth $215,000. Finally, GM Advisory Group LLC grew its stake in shares of Intuitive Surgical by 3.5% in the second quarter. GM Advisory Group LLC now owns 4,213 shares of the medical equipment provider’s stock worth $1,874,000 after acquiring an additional 141 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ISRG shares. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research lifted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. Finally, Citigroup upped their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Up 1.5 %

Shares of NASDAQ:ISRG opened at $592.64 on Friday. The firm’s 50 day moving average price is $539.54 and its 200-day moving average price is $497.69. The stock has a market capitalization of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $362.14 and a twelve month high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock worth $25,012,927. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.